256 related articles for article (PubMed ID: 34422550)
1. Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.
Asif M; Hussain A; Wali A; Ahmed N; Ali I; Iqbal Z; Amir M; Shafiq M; Rasool M
Anal Cell Pathol (Amst); 2021; 2021():4909012. PubMed ID: 34422550
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetical and hematological analysis of chronic myelogenous leukemia patients with a novel case 52XX, t (1;9;22) (q23.3; q34; q11.2), +6, +8, i(9) (q10;q10), +18,+19,+21+der22 t(9;22)(q34;q11).
Asif M; Hussain A; Ali I; Baloch Z; Rasool M; Achakzai NM
Medicine (Baltimore); 2022 Nov; 101(45):e31670. PubMed ID: 36397339
[TBL] [Abstract][Full Text] [Related]
3. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series.
Bayrak AG; Daglar Aday A; Yavuz AS; Nalcaci M; Ozbalak MM; Cefle K; Ozturk S; Palanduz S
Leuk Res; 2021 Dec; 111():106725. PubMed ID: 34634595
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.
Okada M; Satake A; Kaida K; Taniguchi K; Yoshihara S; Ikegame K; Tamaki H; Soma T; Fujimori Y; Ogawa H
Int J Hematol; 2011 Feb; 93(2):243-246. PubMed ID: 21279819
[TBL] [Abstract][Full Text] [Related]
5. A chronic myeloid leukemia case with a variant translocation t(11;22) (q23;q11.2): masked Philadelphia or simple variant translocation?
Acar K; Uz B
Pan Afr Med J; 2018; 30():161. PubMed ID: 30455790
[TBL] [Abstract][Full Text] [Related]
6. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
[TBL] [Abstract][Full Text] [Related]
7. Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India.
Kanakasetty GB; Kuntejowdahalli L; Thanky AH; Dasappa L; Jacob LA; Mallekavu SB; Kumari P
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):52-59. PubMed ID: 27743980
[TBL] [Abstract][Full Text] [Related]
8. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
Kawamoto S; Yamamoto K; Toyoda M; Yakushijin K; Matsuoka H; Minami H
Int J Hematol; 2017 Feb; 105(2):226-229. PubMed ID: 27686674
[TBL] [Abstract][Full Text] [Related]
9. A unique three-way Philadelphia chromosome variant t(4;9;22)(q21;q34;q11.2) in a newly diagnosed patient with chronic phase chronic myeloid leukemia: a case report and review of the literature.
Torii Y; Nanjo K; Toubai T; Hosokawa M; Sato R; Yamada A; Aizawa K; Himuro M; Ito S; Yamamoto M; Magenau J; Wilcox R; Ishizawa K
J Med Case Rep; 2021 May; 15(1):285. PubMed ID: 34030730
[TBL] [Abstract][Full Text] [Related]
10. Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib: A case report.
Shu Y; Yang W; Zhang X; Xu X
Medicine (Baltimore); 2018 Oct; 97(42):e12875. PubMed ID: 30335005
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome.
Koshiyama DB; Capra ME; Paskulin GA; Rosa RF; Oliveira CA; Vanelli T; Fogliatto LM; Zen PR
Ann Hematol; 2013 Jan; 92(2):185-9. PubMed ID: 23064942
[TBL] [Abstract][Full Text] [Related]
12. Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.
Kim TD; Türkmen S; Schwarz M; Koca G; Nogai H; Bommer C; Dörken B; Daniel P; le Coutre P
Haematologica; 2010 Apr; 95(4):582-8. PubMed ID: 20015884
[TBL] [Abstract][Full Text] [Related]
13. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
Crisan AM; Coriu D; Arion C; Colita A; Jardan C
J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
[TBL] [Abstract][Full Text] [Related]
14. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
[TBL] [Abstract][Full Text] [Related]
15. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
Gadzicki D; von Neuhoff N; Steinemann D; Just M; Büsche G; Kreipe H; Wilkens L; Schlegelberger B
Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
[TBL] [Abstract][Full Text] [Related]
16. A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia.
Oudat R; Khan Z; Glassman AB
Arch Pathol Lab Med; 2001 Mar; 125(3):437-9. PubMed ID: 11231500
[TBL] [Abstract][Full Text] [Related]
17. BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.
Campbell LJ; Patsouris C; Rayeroux KC; Somana K; Januszewicz EH; Szer J
Cancer Genet Cytogenet; 2002 Nov; 139(1):30-3. PubMed ID: 12547154
[TBL] [Abstract][Full Text] [Related]
18. Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan.
Tahira B; Asif M; Khan S; Hussain A; Shahwani MN; Malik A; Inayatullah S; Iqbal Z; Rasool M
Asian Pac J Cancer Prev; 2015; 16(9):3793-7. PubMed ID: 25987039
[TBL] [Abstract][Full Text] [Related]
19. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
20. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
